Literature DB >> 31273697

The Visually Mediated Social Preference Test: A Novel Technique to Measure Social Behavior and Behavioral Disturbances in Zebrafish.

William H J Norton1, Line Manceau1, Florian Reichmann2.   

Abstract

Zebrafish are an emerging model in behavioral neuroscience. They display a wide range of measurable behaviors such as locomotion, aggression, anxiety, learning and memory, and social behavior. In addition, the relative ease of genetic manipulation and the increasing availability of disease models mean that zebrafish have gained in popularity as an animal model for various neurological and psychiatric diseases including autism spectrum disorder (ASD). In order to better characterize social behavior and behavioral abnormalities in zebrafish, we have developed the visually mediated social preference (VMSP) test, a novel assay to measure social preference and social novelty in two consecutive 5-min sessions. Using recording and video tracking, the time spent in different areas of the tank, the time spent immobile, swimming speed, and distance moved can be easily measured and analyzed. Untreated experimentally naive AB WT zebrafish typically show a strong preference for spending time near and interacting with a compartment containing unfamiliar conspecifics over the empty compartments during session 1 and a stronger preference for a group of unfamiliar zebrafish over familiar conspecifics from session 1, during session 2 of the test. Research in our lab has shown that the VMSP is suitable to measure the social behavior of individual zebrafish, to uncover social phenotypes of mutant strains, and to better understand animal models of disease that include impaired sociability such as ASD. The current paper provides a step-by-step guide on how to implement and perform this test and highlights important considerations for data acquisition, analysis, and interpretation.

Entities:  

Keywords:  Autism spectrum disorder; Social behavior; Social interaction; Social novelty; Social preference; Zebrafish

Mesh:

Year:  2019        PMID: 31273697     DOI: 10.1007/978-1-4939-9554-7_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

Review 1.  Modelling ADHD-Like Phenotypes in Zebrafish.

Authors:  Barbara D Fontana; William H J Norton; Matthew O Parker
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  Exposure to leucine alters glutamate levels and leads to memory and social impairment in zebrafish.

Authors:  Isabela da Silva Lemos; Leticia Burato Wessler; Mariane Bernardo Duarte; Guilherme Lodetti da Silva; Henrique Teza Bernardo; Gabriela Candiotto; Carolina Antunes Torres; Fabricia Petronilho; Eduardo Pacheco Rico; Emilio Luiz Streck
Journal:  Metab Brain Dis       Date:  2022-08-30       Impact factor: 3.655

3.  Transcriptomic underpinnings of high and low mirror aggression zebrafish behaviours.

Authors:  Florian Reichmann; Johannes Pilic; Slave Trajanoski; William H J Norton
Journal:  BMC Biol       Date:  2022-05-02       Impact factor: 7.364

4.  Reelin Signaling Controls the Preference for Social Novelty in Zebrafish.

Authors:  Elisa Dalla Vecchia; Vincenzo Di Donato; Andrew M J Young; Filippo Del Bene; William H J Norton
Journal:  Front Behav Neurosci       Date:  2019-09-19       Impact factor: 3.558

Review 5.  Using Zebrafish to Model Autism Spectrum Disorder: A Comparison of ASD Risk Genes Between Zebrafish and Their Mammalian Counterparts.

Authors:  Victoria Rea; Terence J Van Raay
Journal:  Front Mol Neurosci       Date:  2020-11-11       Impact factor: 5.639

6.  Social Preference Tests in Zebrafish: A Systematic Review.

Authors:  Asahi Ogi; Rosario Licitra; Valentina Naef; Maria Marchese; Baldassare Fronte; Angelo Gazzano; Filippo M Santorelli
Journal:  Front Vet Sci       Date:  2021-01-22

7.  Towards Modeling Anhedonia and Its Treatment in Zebrafish.

Authors:  Murilo S de Abreu; Fabiano Costa; Ana C V V Giacomini; Konstantin A Demin; Konstantin N Zabegalov; Gleb O Maslov; Yuriy M Kositsyn; Elena V Petersen; Tatiana Strekalova; Denis B Rosemberg; Allan V Kalueff
Journal:  Int J Neuropsychopharmacol       Date:  2022-04-19       Impact factor: 5.678

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.